• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 4. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 5. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952

Benzene,1-bromo-3-[2-(trimethylsilyl)ethynyl]- (CAS No. 3989-13-7): A Versatile Intermediate in Organic Synthesis

Benzene,1-bromo-3-[2-(trimethylsilyl)ethynyl]- (CAS No. 3989-13-7) is a specialized organic compound that has garnered significant attention in recent years due to its unique structural features and wide range of applications in pharmaceutical research, material science, and organic electronics. This compound, which combines a brominated benzene ring with a trimethylsilyl-protected ethynyl group, serves as a valuable building block in cross-coupling reactions and other synthetic transformations.

The growing interest in Benzene,1-bromo-3-[2-(trimethylsilyl)ethynyl]- reflects broader trends in chemical research, where scientists are increasingly focused on developing efficient synthetic methodologies and functional materials. Recent searches on scientific databases and AI platforms reveal that researchers are particularly interested in questions like: "How does the trimethylsilyl protecting group affect the reactivity of terminal alkynes?" and "What are the latest applications of bromo-aryl compounds in medicinal chemistry?" These queries highlight the compound's relevance to current scientific discourse.

From a structural perspective, Benzene,1-bromo-3-[2-(trimethylsilyl)ethynyl]- offers several advantages for synthetic chemists. The bromine substituent at the 1-position makes it an excellent candidate for palladium-catalyzed coupling reactions, while the trimethylsilyl-ethynyl group at the 3-position provides a protected alkyne functionality that can be easily deprotected for further transformations. This dual functionality has made the compound particularly valuable in the synthesis of conjugated polymers and small molecule semiconductors, which are crucial components in organic photovoltaic devices and OLED technologies.

In pharmaceutical research, Benzene,1-bromo-3-[2-(trimethylsilyl)ethynyl]- serves as a key intermediate in the synthesis of various biologically active compounds. The ability to selectively modify either the bromine or alkyne functionality allows medicinal chemists to create diverse molecular architectures. Recent studies have explored its use in preparing kinase inhibitors and GPCR modulators, addressing current therapeutic needs in areas such as oncology and neurological disorders.

The compound's stability and handling characteristics make it particularly attractive for industrial applications. Unlike many reactive organometallic intermediates, Benzene,1-bromo-3-[2-(trimethylsilyl)ethynyl]- can be stored and handled with standard laboratory precautions, contributing to its popularity in both academic and industrial settings. This practical advantage aligns with the growing emphasis on process safety and sustainable chemistry in modern chemical manufacturing.

Recent advancements in click chemistry and bioorthogonal reactions have further expanded the utility of Benzene,1-bromo-3-[2-(trimethylsilyl)ethynyl]-. The protected alkyne group can participate in copper-catalyzed azide-alkyne cycloadditions (CuAAC) after deprotection, enabling the construction of complex molecular architectures. This property has made the compound valuable in bioconjugation applications and the development of molecular probes for biological imaging.

From a market perspective, the demand for Benzene,1-bromo-3-[2-(trimethylsilyl)ethynyl]- has grown steadily, reflecting broader trends in the fine chemicals sector. Suppliers have reported increasing inquiries from both pharmaceutical companies and material science research groups, particularly in regions with strong biotechnology and electronics industries. The compound's versatility ensures its continued relevance across multiple scientific disciplines.

Quality control and characterization of Benzene,1-bromo-3-[2-(trimethylsilyl)ethynyl]- typically involve advanced analytical techniques. NMR spectroscopy (particularly ¹H and ¹³C NMR) remains the primary method for verifying the compound's structure and purity, while mass spectrometry provides additional confirmation. These analytical methods ensure that researchers receive material of consistent quality for their synthetic applications.

Looking to the future, Benzene,1-bromo-3-[2-(trimethylsilyl)ethynyl]- is poised to maintain its importance in chemical research. As synthetic methodologies continue to evolve and new applications emerge in nanotechnology and molecular electronics, this compound's unique combination of reactivity and stability will likely ensure its continued use as a versatile building block in organic synthesis.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)